XPONANCE, INC. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$247,000
-3.1%
3,624
-42.1%
0.01%0.0%
Q1 2021$255,000
-2.3%
6,263
+3.8%
0.01%
-16.7%
Q4 2020$261,000
-22.1%
6,031
-0.6%
0.01%
-25.0%
Q3 2020$335,000
-12.3%
6,067
+0.3%
0.01%
-20.0%
Q2 2020$382,0006,0460.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 383,702$14,581,0007.71%
Perceptive Advisors 5,148,910$195,658,0005.23%
Grace Capital 312,514$11,876,0004.65%
NEXTHERA CAPITAL LP 549,231$20,871,0004.00%
Asymmetry Capital Management, L.P. 103,449$3,931,0003.63%
Camber Capital Management LP 2,075,000$78,850,0003.37%
Casdin Capital, LLC 440,000$16,720,0002.03%
EMORY UNIVERSITY 53,951$2,050,0001.34%
ArchPoint Investors 129,435$4,919,0001.34%
Ghost Tree Capital, LLC 150,000$5,700,0001.21%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders